Compare MANU & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | MANU | HAE |
|---|---|---|
| Founded | 1878 | 1971 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Services-Misc. Amusement & Recreation | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.0B | 2.8B |
| IPO Year | 2012 | 1996 |
| Metric | MANU | HAE |
|---|---|---|
| Price | $17.49 | $59.99 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 9 |
| Target Price | N/A | ★ $84.13 |
| AVG Volume (30 Days) | 240.8K | ★ 535.6K |
| Earning Date | 06-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 44.54 |
| EPS | N/A | ★ 2.46 |
| Revenue | N/A | ★ $910,373,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $16.31 | $5.23 |
| P/E Ratio | ★ N/A | $24.42 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.22 | $47.32 |
| 52 Week High | $18.94 | $87.32 |
| Indicator | MANU | HAE |
|---|---|---|
| Relative Strength Index (RSI) | 53.18 | 50.65 |
| Support Level | $17.09 | $48.47 |
| Resistance Level | $18.08 | $62.78 |
| Average True Range (ATR) | 0.42 | 1.88 |
| MACD | -0.04 | 0.17 |
| Stochastic Oscillator | 55.56 | 54.65 |
Manchester United PLC operates as a professional football club with related activities, generating revenue prominently through commercial, broadcasting, and matchday segments. The commercial segment monetizes the various brands via sponsorships, retail, merchandising, apparel, and product licensing. Broadcasting revenue comes from television rights linked to football leagues and competitions, alongside content delivered through its dedicated TV channel all over the globe. Matchday income includes ticket sales, hospitality, merchandise, and services at its stadium. Manchester United is based in England. The company's operations and fan base extends to many countries, supporting a diversified revenue model based on brand engagement and football-related content.
Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.